The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs is a research paper published in European Journal of Pharmaceutical Sciences (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Taichung Veterans General Hospital
Grant: TCVGH-T1137809
Chang Gung Memorial Hospital
Grant: CMRPD1P0151
Chang Gung Memorial Hospital
Grant: BMRPC17
Chang Gung Memorial Hospital
Grant: CMRPD1M0582
National Science and Technology Council
Grant: 114-2320-B-182-021
National Science and Technology Council
Grant: 113-2320-B-182-021